SPL 1.03% 9.8¢ starpharma holdings limited

Ann: VivaGel BV sales and distribution agreement MENA region, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 92 Posts.
    lightbulb Created with Sketch. 22
    Well AB, it looks to be another poorly crafted deal just like the deals preceding it. So, I can either believe that the CEO and Board genuinely think it is a good deal, in which case I suspect they will prove to be shown to be commercially incompetent once again, or, I can believe that they know it is a poorly crafted deal but if it ticks off a KPI that leads to their own personal benefit, who cares? This is a pretty cynical view formed after years of continual disappointment in response to persistent lack of commercial progress (evidence based). JF appears to have been remunerated very well during her tenure with her legacy being the share price driven into the dustbin. It appears that with a change in the CEO, nothing else has actually changed and it is business as usual.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.